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Summary : Cyclins are regulatory subunits of cyclin-dependent kinases (CDKs) and required for the
activation of CDKs. Human cyclin A interacts with CDK via its central cyclin box domain, while the
function of the C-terminal domain is largely unknown. We isolated a novel mutation lacking any
associated CDK activity at a cluster of charged amino acids in the C-terminal domain. This mutant
showed marked protein instability. It did not activate CDK even when stabilized with the protea-
some inhibitor, suggesting that the charged amino acid cluster in the C-terminal domain is required
for the activation of CDK and is also involved in the protein stability of human cyclin A.
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Introduction
Key transitions within the cell cycle of eukaryotes
are controlled by cyclin-dependent kinases (CDKs).
The kinase activity of CDKs depends on their associa-
tion with the activating subunits, the cyclins. Cyclins
are di#erentially expressed during the cell cycle and
speciﬁc cyclin-CDK complexes are assembled and ac-
tivated at di#erent cell cycle stages. Each of these
cyclin-CDK complexes executes a unique cell cycle
function, which is essential for cell cycle progression.
One of the two major functions of cyclin is to pro-
mote activation of CDK. This is ascribed to ”cyclin
box”, a conserved domain within all cyclins that is
necessary for binding to CDK+. The activation of
CDK can be detected by assaying for the kinase activ-
ity using a non-speciﬁc CDK substrate such as histone
H+. The other major function of cyclin is to target
CDK to its speciﬁc substrates. Presumably, cyclin-
speciﬁc domains other than the cyclin box are respon-
sible for that function. However, there is only limited
information on the exact cyclin domains determining
the substrate speciﬁcity. Systematic analyses of the
domains speciﬁc for each cyclin would be very impor-
tant for clarifying the cyclin-speciﬁc substrates, which
represent a major gap in our current knowledge of cell
cycle control.
Cyclin A plays some important roles in vertebrate
cell cycle control since it is essential for the onset of
both DNA replication and mitosis,. It has been im-
plicated by previous deletion analyses of Xenopus
cyclin A- that it can be separated into three domains :
the N-terminal domain which is essential for a periodic
degradation of the cyclin A protein, the central cyclin
box domain, and the C-terminal domain whose func-
tion is largely unknown. More recently, X-ray crystal-
lography studies on human cyclin A-CDK, complex
have revealed that cyclin A interacts with CDK via the
cyclin box domain and the C-terminal domain is basi-
cally free of the CDK interaction.. The C-terminal
domain contains several clusters of charged amino acid
residues which are situated on the protein surface.
This fact has prompted us to analyze the function of
the C-terminal domain by targeting these charged clus-
ters for mutagenesis. Here we show that one of such
clusters is essential for the CDK activation and is also
involved in the protein stability.
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Materials and Methods
(+) Cell cultures, plasmids, and transfections
NIH-T- cells (clone 1) were obtained from C. Sherr
(St. Jude Children’s Hospital, Memphis TN, USA) and
grown in Dulbecco’s modiﬁed Eagle medium (DMEM)
supplemented with +* fetal bovine serum (FBS) at
-1/ / CO,.
Mammalian expression vector pCS,MT/ carrying
myc-tagged human cyclin A was obtained from B.
Clurman (Fred Hutchinson Cancer Research Center,
Seattle WA, USA). Brieﬂy, it contains 0 x myc epitope
tag fused in frame to the N-terminus of human cyclin A
cDNA under the control of CMV promoter. This
plasmid was used for constructing all the alanine-
scanning cyclin A mutants by site-directed
mutagenesis using the methods described by KUNKEL et
al.0
Transfections were performed by the modiﬁed Ca-
phosphate method1, using /mg (or otherwise as in-
dicated) of plasmid DNA per ,+*/ cells in 0*-mm
culture dishes. +0 h after the transfection, cells were
rinsed once with phosphate-bu#ered saline (PBS) and
grown in fresh DMEM/+* FBS for an additional ,. h
before harvest.
Peptide aldehydes N-acetyl-leu-leu-norleucinal
(LLnL, a proteasome inhibitor) and N-acetyl-leu-leu-
methioninal (LLM, a calpain inhibitor) were purchased
from Sigma and dissolved at ,* mM in DMSO. These
inhibitors were added at the ﬁnal concentration of /*
mM to the medium around ,. h after transfection.
Cells were lysed as below with or without the addition
of N-ehtylmaleimide (NEM) to the RIPA bu#er.
(,) Immunoprecipitation, H+ kinase assay, and west-
ern blotting analysis
Cells were rinsed once with Tris-bu#ered (pH 1..)
saline and lysed directly on 0*-mm dishes on ice in
RIPA bu#er containing protease and phosphatase in-
hibitors (+*mM Tris-HCl pH 1.., *.+/M NaCl, *./ NP-
.*, +*mg/ml each of aprotinin, leupeptin, and pepstatin,
/*mM NaF, +mM Na-vanadate), followed by scraping.
Cell extracts were cleared for debris and stored at
2*.
Immunoprecipitation was performed as described1
and histone H+ kinase assays were done by standard
methods2. Western blotting analyses were carried
out as described previously3 with some modiﬁcations
such as using LumiLight western detection substrates
and LumiImager (Roche diagnostics) to visualize spe-
ciﬁc protein bands.
Results and discussion
+. Isolation of a novel C-terminal mutation, cyclin A
.+*, causing the loss of CDK activation.
We have introduced alanine-scanning mutations at
seven sites within the C-terminal domain of human
cyclin A. cDNAs containing these mutations were
transiently transfected to NIH-T- cells and expressed
as myc-tagged proteins. The exogenous proteins were
then immunoprecipitated with anti-myc antibodies
and assayed for their associated histone H+ kinase
activity. We found that one of those mutants, cyclin
A.+*, in which three consecutive charged amino acid
residues are substituted by alanines (Fig. +A), lacked
any associated H+ kinase activity (Fig. +B). All the
other C-terminal mutants exhibited normal H+ kinase
activity, which is comparable to the wild type (data not
shown). A control mutant cyclin A,++, which carries
an alanine substitution at a highly conserved arginine
residue within the cyclin box (Fig. +A), also showed no
associated H+ kinase activity (Fig. +B). This is quite
reasonable since the Arg,++ residue is conserved
among all the cyclins and its alteration has been shown
to abolish CDK activation-. On the other hand, the
cyclin A.+* is a novel C-terminal domain mutation
which causes the loss of CDK activation.
,. The cyclin A.+* mutation, as well as the cyclin
box mutation cyclin A,++, causes protein instability.
We next checked the expression level of the cyclin A
.+* and cyclin A,++ proteins. Fig. ,A shows anti-
cyclin A immunoblotting of the extracts from NIH-T-
cells transiently transfected with the wild-type and the
mutant cyclin A cDNAs. The steady-state amount of
both mutant cyclin A proteins were remarkably
decreased as compared to the wild-type protein. Since
cyclin A has been known as one of the targets for
proteasome-mediated proteolysis, we asked if the low
expression level of the mutant cyclin A proteins was
due to an acceleration of their proteolysis. NIH-T-
cells were transiently transfected with the wild-type
and mutant cDNAs in the presence of a proteasome
inhibitor LLnL or a calpain inhibitor LLM, which is
structurally related to LLnL but does not inhibit the
proteasome. Because LLnL blocks the degradation of
ubiquitinated proteins but does not inhibit the conju-
gation of ubiquitin to the target proteins, LLnL treat-
ment results in the accumulation of polyubiquitinated
proteins. As shown in Fig. ,B, the exogenous cyclin
A proteins, either wild-type or mutant, were greatly
stabilized by treatment with LLnL but not with LLM,
indicating that the low expression of the mutant pro-
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teins is indeed due to an acceleration of proteasome-
mediated proteolysis. When treated with LLnL,
ladders of slower and faster migrating species were
detected in the mutant protein blots, while only one
slow migrating band was apparent in the wild-type
protein blot. These results also suggest that the
mutant cyclin A proteins are polyubiquitinated and
targeted to proteolysis at a much higher e$ciency than
the wild-type protein.
Instability of the cyclin A,++ mutant protein was
unexpected, since previous studies on Xenopus oocyte
cyclin A have shown that an equivalent mutation at
the conserved arginine residue exhibits the opposite
phenotype+*. The Xenopus mutant protein is resistant
to proteolysis, suggesting that binding to CDK is neces-
sary for cyclin A degradation. However, the human
cyclin A used in this study belongs to a somatic-type
subfamily (cyclin A,), which is structurally distinct
from a germ-line type (cyclin A+) including Xenopus
oocyte cyclin A. Several lines of evidence have
suggested that these two types are di#erentially
regulated in terms of protein stability++. We therefore
propose that the human somatic-type cyclin A is more
easily targeted to proteolysis when it is dissociated
from CDK. This also seems to account for the instabil-
ity of the cyclin A.+* protein since it possesses no
intrinsic CDK-activating function like the cyclin A,++
protein (see below).
-. The cyclin A.+* mutation site is essential for ac-
tivating CDK.
To discern the intrinsic e#ects of the cyclin A,++ and
cyclin A.+* mutations on CDK activation, we assayed
the H+ kinase activity associated with the mutant pro-
teins when stabilized. NIH-T- cells were transfected
with increasing amounts of the myc-tagged cyclin A
cDNAs in the presence of LLnL, followed by im-
munoprecipitating their extracts with anti-myc anti-
Fig. , Cyclin A,++ and Cyclin A.+* mutant
proteins are unstable
(A) Anti-cyclin A immunoblotting of extracts from NIH
-T- cells transfected with the myc-tagged cyclin A
cDNAs. MT-cycA and endo cycA represent myc-
tagged and endogenous (mouse) cyclin A, respectively.
The anti-cyclin A antibodies crossreact with both
human and mouse cyclin A.
(B) Proteasome inhibitor LLnL stabilizes the mutant
cyclin A proteins. NIH-T- cells were transfected with
myc-tagged wild-type (/mg) or mutant (/*mg) cyclin A
cDNA, treated with LLnL or LLM, lysed in the presence
of NEM, and the extracts were immunoblotted with
anti-myc antibodies.
Fig. + A novel mutation cyclin A.+*
(A) Schematic representation of human cyclin A and
the location (residue number) of cyclin A mutations.
(B) The cyclin A,++ and Cyclin A.+* mutations
exhibited no CDK activation. NIH-T- cells were
transfected with the myc-tagged cyclin A cDNAs or
vector alone (vec), followed by immunoprecipitation
and histon H+ kinase assay of the cell extracts.
Autoradiograph of the kinase reaction samples resolved
by +, SDS-PAGE is shown.
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bodies and assaying for the associated H+ kinase activ-
ity. Fig. -A shows that the amounts of the mutant
cyclin A proteins in the immunoprecipitates were
almost comparable to that of the wild-type protein.
Nevertheless, as shown in Fig. -B, the H+ kinase ac-
tivities associated with the mutant cyclin A proteins
were as low as background level. These results indi-
cate that those mutations abolish the CDK-activating
function of cyclin A independently of their e#ect on
the protein stability.
As mentioned above, the cyclin A,++ mutant is ex-
pected to exhibit the CDK activation-negative pheno-
type because the mutation resides within the cyclin
box. In contrast, the cyclin A.+* mutation resides in
the C-terminal domain of cyclin A. The only
mutational analysis reported to date of the C-terminal
domain is the deletion analysis of Xenopus oocyte
cyclin A, which has shown that its C-terminal +.-amino
acid region is essential for the CDK activation-. This
region is also conserved at the C-terminus of the
human cyclin A, but the cyclin A.+* mutation site is
not located within the corresponding region. It is also
di$cult to compare our results directly with the
Xenopus cyclin A data, since a human cyclin A muta-
tion within the C-terminal region, which is essential for
the CDK activation in Xenopus, did not a#ect the CDK
activation (data not shown). The cluster of three
charged amino acid residues, where the cyclin A.+*
mutation resides, does not directly interact with the
CDK polypeptide chain, according to the X-ray crystal-
lography. Instead, the cluster might be required for
the integrity of the structure of cyclin box domain
since it is located in the proximity of the a-helix con-
taining the Arg,++ residue. In any case, our identiﬁc-
ation of this charged amino acid cluster as an essential
site for the protein stability and the CDK activation
should provide insight into the C-terminal domain-
speciﬁc functions of human cyclin A.
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ヒトサイクリンAの C末端領域に存在する荷電
アミノ酸クラスタの +つはサイクリン依存性
キナゼの活性化に必要である
千葉櫻 拓*吉川博文*
平成 +,年 ++月 -*日受付 /平成 +-年 +月 +2日受理
要約 : サイクリンはサイクリン依存性キナゼ CDKの制御サブユニトであり CDKの活性化に必要であ
る ヒトサイクリンAはその中央にあるサイクリンボックス領域を介して CDKと相互作用するが その C
末端側領域の機能は殆ど未知である 我は C末端領域の荷電アミノ酸クラスタの +つにおける変異と
して CDK活性を伴わない変異を新規に分離した この変異は顕著なタンパク不安定性を示したが プロテ
アソム阻害剤によってタンパクを安定化させても CDK活性を伴わなかったことより その C末端領域の
荷電アミノ酸クラスタが CDK活性化に必要でありまたタンパク安定性にも関与することが示唆された
キワド : サイクリンA サイクリン依存性キナゼ CDK CDK活性化 タンパク安定性
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